MAM
MPM Asset Management Portfolio holdings
AUM
$43.3M
This Quarter Return
+33.26%
1 Year Return
-54.44%
3 Year Return
+14.05%
5 Year Return
-29.8%
10 Year Return
-11.6%
AUM
$226M
AUM Growth
–
Cap. Flow
+$226M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
10
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$81M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$60M |
| 3 |
Verastem
VSTM
|
$24.1M |
| 4 |
Pacira BioSciences
PCRX
|
$23.9M |
| 5 |
KBIO
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
|
$14.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 64.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $81M | 35.87% | +2,880,485 | New | +$81M |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $60M | 26.55% | +2,441,344 | New | +$60M |
|
|
3
Verastem
VSTM
$569M
| $24.1M | 10.67% | +1,736,171 | New | +$24.1M |
|
|
4
Pacira BioSciences
PCRX
$1.2B
| $23.9M | 10.58% | +824,255 | New | +$23.9M |
|
|
KBIO
5
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
| $14.9M | 6.6% | +2,632,928 | New | +$14.9M |
|
6
Altimmune
ALT
$338M
| $10.1M | 4.47% | +6,347,614 | New | +$10.1M |
|
|
AVEO
7
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $5.52M | 2.44% | +2,208,961 | New | +$5.52M |
|
|
ZLCS
8
DELISTED
ZALICUS INC COM NEW
ZLCS
| $3.12M | 1.38% | +5,566,980 | New | +$3.12M |
|
|
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
| $1.9M | 0.84% | +1,669,753 | New | +$1.9M |
|
|
PETX
10
DELISTED
Aratana Therapeutics, Inc.
PETX
| $1.37M | 0.6% | +180,505 | New | +$1.37M |
|